To compare pregnancy and economic outcomes in women receiving inpatient vs outpatient tocolysis with continuous subcutaneous terbutaline (SQT).
INTRODUCTION
It is estimated that each year 700,000 women in the United States experience at least one antepartum hospitalization related to a pregnancy complication. 1 These hospitalizations account for greater than 2.8 million hospital days, and $4 billion in hospital charges annually. 1 Largely dependent on the population studied, approximately 1% to 16% of all antenatal hospitalizations are prolonged (>3 days) in duration, with many women remaining as inpatients until delivery. [1] [2] [3] Over 35% of antenatal hospitalizations culminating in delivery have a duration of eight or more days. 2 One-quarter to nearly one-half of all antenatal hospital admissions are due to symptoms of preterm labor. [1] [2] [3] [4] [5] In the United States, total expenditures for preterm labor hospitalizations were estimated in excess of $820 million. 6 In an effort to halt the progression of labor and delay delivery, tocolytic treatment is frequently administered to women presenting with preterm labor symptoms who are without conditions contradictory to pregnancy prolongation. Once the patient's acute condition is stabilized, oral or low-dose continuous subcutaneous tocolysis may be continued in an effort to maintain uterine quiescence.
Following stabilization of an acute episode of preterm labor, increased observation and frequent patient assessment is generally necessary to readily detect recurrence of the condition. Based on the patient's prescribed treatments, current clinical status, obstetric history, living arrangements, and insurance company recommendations and policies, this increased surveillance may occur as an inpatient with a prolonged hospitalization or as an outpatient utilizing frequent doctor visits, outpatient nursing services or a combination thereof. Owing to the perceived degree of risk for early delivery and its associated neonatal morbidity and mortality, many clinicians in the United States frequently employ protracted hospitalization for women following a diagnosis of preterm labor, vs utilizing outpatient management programs.
The purpose of this study was to compare pregnancy and economic outcomes of inpatient vs outpatient management of women with stabilized preterm labor treated with low-dose continuous subcutaneous terbutaline (SQT).
MATERIALS AND METHODS
The study population was extracted from a centralized perinatal database comprised of clinical information on women throughout the United States who received services related to a high-risk pregnancy condition. These outpatient obstetrical services were provided by Matria Healthcare, Marietta, Georgia. Information within this database is collected prospectively from the patient and her physician during the course of patient care and includes medical and obstetrical history, diagnoses and treatment, daily clinical data related to the patient's diagnoses, interventions received, and maternal and neonatal outcome data. At initiation of prescribed service the patient provides written, informed consent, allowing the use of blinded clinical data for research purposes.
Patients in this study were hospitalized for stabilization of an acute episode of preterm labor and thereafter prescribed SQT therapy between 24.0 and 33.9 weeks' gestation. Enrollment occurred between January 1995 and December 1999. Women with cervical dilatation >3 cm, or with maternal/fetal instability requiring inpatient care (e.g., pre-eclampsia, placenta previa, vaginal bleeding, cerclage), were excluded. To harmonize the data, we also excluded women remaining inpatient that had a hospital stay of less than 6 days before delivery. Those with singleton or twin gestation, a documented cervical exam at start of SQT, and pregnancy outcome data were eligible for inclusion. Patients meeting inclusion/exclusion criteria were divided into two groups: those discharged to outpatient management and those remaining hospitalized for inpatient management. Women who were stable, yet remained hospitalized (inpatient group), were matched 1:1 to women discharged to home care services (outpatient group) by cervical dilatation at start of SQT, gestational age at start of SQT, and fetal number.
In both groups, SQT was administered via a portable microinfusion pump. The infusion device was programmed to deliver a continuous basal rate and intermittent bolus doses. Each patient's dosage schedule was individualized based on her uterine activity pattern, subjective symptoms, gestation type (singleton, twin), and body mass index. At initiation of SQT, patients received individualized instruction from a skilled perinatal nurse pertaining to the device used to administer medication, as well as infusion initiation technique, site selection and care, syringe change, and the procedure for administering an unscheduled (PRN) bolus per physician's order for increased uterine activity or persistent increase in preterm labor symptoms. Patients were instructed on emergency procedures and appropriate reporting of adverse reactions related to medications and/or problems with the infusion device.
Women discharged to outpatient services additionally received a home visit by a registered nurse. During this home visit the nurse assessed the patient's environment and her ability to perform the procedures necessary to maintain SQT delivery in the home. The patient was also instructed on the use of a home uterine activity monitor. Following the initial home visit, follow-up visits were conducted on an as-needed basis. Uterine activity data were collected, at a minimum, 1 hour twice daily, 8 to 10 hours apart, and as needed based on an increase in preterm labor signs and symptoms. Data were transmitted to a regional perinatal call center staffed with skilled obstetric nurses who evaluated the data received and completed a telephonic assessment of signs and symptoms relative to preterm labor. The physician was notified when uterine activity exceeded an established threshold (generally four to six contractions per hour) for 2 consecutive hours, or if the patient reported persistent preterm labor symptoms. Patients were instructed to have frequent rest periods, though strict bedrest was not expected to be maintained. Home nursing services were adjunctive to, and not in place of, physician office visits. Medication prescription and dosing, antenatal testing, hospital admission, and recommended patient activity level was at the discretion of each patient's attending physician.
Women in the inpatient group were managed per hospital policy and assessed by nurses employed by the facility. Matria nursing and pharmacy staff maintained frequent contact with the patient, her physician, as well as the inpatient nursing personnel, and consulted as needed or requested regarding medication dosing, pump programming, and supplies. Uterine monitoring was performed per physician order and according to hospital protocol.
To evaluate cost-effectiveness of treatment, a model was applied where charges incurred during the study period for antepartum hospitalization, outpatient services and nursery days were standardized. In this model, maternal antepartum hospital days were estimated at $900/day, outpatient nursing services with SQT at $275/day, pump rental while hospitalized $50/day, normal newborn nursery at $500/day, and NICU at $2000/day. The estimated cost per day for hospital care combines accommodation and ancillary charges and does not take into account indirect costs. Physician charges, increased first-year, and lifetime medical costs were not considered in the model.
Pregnancy and cost outcomes were compared using matchedpairs statistical analysis: paired Student's t, Wilcoxon signed ranks and McNemar's w 2 test statistics. Two-sided p-values <0.05 were considered statistically significant. Birth weights, nursery length of stay, and costs were averaged for each twin gestation resulting in one value per variable per pregnancy and analyzed as such. The primary study outcomes were the incidence of preterm birth and maternal/infant costs of care.
RESULTS
In this study, 90 matched pairs (52 singleton pairs and 38 twin pairs) were analyzed. Maternal characteristics were similar between the inpatient and outpatient groups (Table 1) . In all, 36 women (40%) in each group had cervical dilatation of Z2 cm (mean 1.3±1.1 cm in each group, matched variable) and 73.3% (66) of each group were <32 weeks' gestation at start of SQT (29.9±2.2 weeks each group, matched variable). Totally, 46 (51.1%) women remaining inpatient and 47 (52.2%) outpatients had other living children.
As expected, women in the inpatient group had a significantly greater number of hospital days vs the outpatient group (22.4±13.6 vs 4.2±5.2 days, p<0.001). In total, 61 (67.8%) women in the inpatient group were hospitalized for at least 14 days, while 28 (31.1%) remained hospitalized for Z4 weeks. The total daily dose of subcutaneous terbutaline was similar between the groups (3.7±0.9 mg/day-inpatient group vs 3.6±0.9 mg/dayoutpatient group, p ¼ 0.658). Concomitant oral tocolytics (nifedipine, indomethacin, or magnesium gluconate) were prescribed for nine (10%) in the inpatient group and 10 (11.1%) in the outpatient group (p ¼ 1.000). Recurrent preterm labor and successful retreatment of the condition with intravenous magnesium sulfate occurred in seven (7.8%) inpatients and nine (10%) of the outpatient group (p ¼ 0.804).
Pregnancy prolongation from gestational age at SQT start until delivery was 29.6±19.7 days in the inpatient group and 40.9±18.1 days in the outpatient group (p<0.001). Outcome data are presented in Table 2 . The preterm birth rate was higher for inpatient vs outpatient subjects (p ¼ 0.043), and inpatients had an earlier gestational age at delivery than outpatients (34.1±2.9 vs 35.8±1.9 weeks, p<0.001). The incidence of preterm delivery at <34 weeks was significantly higher in the inpatient group (42.2% vs 13.3%, p<0.001). There were no differences between the groups in the incidence of recurrent preterm labor with delivery (72.2% of inpatients vs 58.9% of outpatients, p ¼ 0.074), or elective delivery (8.9% of inpatients vs 14.4% of outpatients, p ¼ 0.359), although the timing of these events had an impact on the overall gestational age at delivery. The gestational age at delivery for women in the inpatient group with delivery due to recurrent preterm labor was 33.5±2.2 vs 34.9±1.6 weeks in the outpatient group (p<0.001). Elective delivery (induced labor or scheduled Cesarean) occurred at 36.2±1.6 weeks in the inpatient group and 36.9±1.8 weeks in the outpatient group (p ¼ 0.337). As shown in Table 2 , the birth weight was almost 1 pound higher among outpatient women's neonates (p<0.001) as was the percentage of infants >2500 g (61.2% vs 38.8%, p<0.05). The percentage of infants admitted to the NICU was less than half (26.2%, vs 57.3%, p<0.001) in the outpatient group as were the total neonatal days (13.6±16.0 vs 5.2±6.8, p<0.001). There was one perinatal death in the inpatient group: a singleton delivered at 32 weeks due to cardiac anomalies. No serious maternal adverse events were reported.
Costs inclusive of antepartum hospitalization, outpatient services, and nursery charges are presented in Table 3 . Total costs were less for women in the outpatient group ($25,540±$25,847 vs $56,089±$47,944, p<0.001). The greatest mean differences were noted in per-pregnancy NICU and antenatal hospitalization costs.
SIGNIFICANCE
Prenatal hospitalization is a common occurrence that creates an economic burden for families and third-party payers. In one report, 26.8±1.6% of pregnant, enlisted servicewomen had at least one antepartum hospitalization prior to delivery. 2 Haas 1 showed a prenatal admission rate of 17.7% in a cohort from a single institution with the median total charge per nondelivery hospitalization of $4682 vs $11,623 for those with prolonged hospitalization prior to delivery. While in yet another report using data from a national managed care organization, the rate of antepartum hospital admission was 8.7%. 3 The frequency of prolonged hospitalization (>3 days) preceding delivery varies widely based on the population studied, occurring in as few as 1% or as many as 16% of women hospitalized for pregnancy complications. [1] [2] [3] Preterm labor is the leading cause of antenatal hospital admission, and can lead to multiple hospitalizations during pregnancy, maternal morbidity, and neonatal mortality. [1] [2] [3] [4] [5] Annually, in the United States, total expenditures for preterm laborrelated hospitalizations are estimated to be in excess of $820 million. 7 Preterm labor places a pregnancy at an undeniable risk for preterm birth. Hospitalization is often required for timely assessment and treatment of an acute pregnancy complication such as preterm labor, although there is great financial incentive to reduce admission frequency and/or length of inpatient stay. When preterm labor is treated successfully and the threat of immediate delivery has abated, a treatment plan must be developed that provides for close patient observation for recurrence of uterine activity and/or preterm labor symptoms. To address the need for on-going observation and follow-up, outpatient programs are available that provide nursing services, home uterine activity monitoring, 24/7 telephonic nursing availability for patient assessment and intervention, as well as assistance in coordination of required social services. Unfortunately, some insurance plans/ third-party payers will not reimburse for these outpatient services. This may result in the need for continued hospital confinement when heightened observation is warranted.
The purpose of the current study was to compare pregnancy and economic outcomes in women with stabilized preterm labor and prolonged inpatient observation vs outpatient observation. However, there are limitations of the current study, which need to be acknowledged. This was not a randomized controlled trial, which might lead to the potential of bias by including patients who were from different populations. On the other hand, in the current study, the data were prospectively collected before group assignment, and the study population was identified using stringent criteria and then matched prior to outcome analysis. All patients had been weaned from intravenous tocolytics and were in stable condition. Records were carefully reviewed to eliminate patients with conditions that may have required prolonged hospital care, such as: known fetal compromise, maternal hypertension, placenta previa, vaginal bleeding, cerclage, cervical incompetence, or cervical dilatation >3 cm. To our knowledge, there were no clinical contraindications to outpatient care in any patient included in this analysis. Also, the critical factors such as gestational age, fetal number, and cervical dilatation at the start of therapy were all matched. Demographic characteristics in each group were similar. We chose to study only patients prescribed SQT. Lam, in 1988, first described using a microinfusion pump to subcutaneously administer a low-dose continuous basal rate and scheduled bolus doses of terbutaline to nine women that experienced recurrent preterm labor while receiving oral terbutaline. 8 While hospitalized, women were instructed on the procedures necessary to maintain the subcutaneous infusion device then discharged home with an outpatient tocodynamometer and telephonic nursing services. Since 1988 there have been many publications further describing the use of SQT in several different types of patient populations. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Other authors have compared inpatient to outpatient management of nonacute patients. A previous study of home vs hospital management of women with preterm labor showed no significant differences in pregnancy outcomes, concluding that home care management is an efficient and acceptable option for women experiencing preterm labor. 21 In contrast, the present study showed improved pregnancy outcomes with home vs hospital management. We can only speculate that patients hospitalized received more active, daily management along with increased testing and related maternal stress, perhaps leading to an earlier termination of pregnancy. Other studies have shown the ineffectiveness of prolonged prophylactic hospitalization in the management of twin gestations prior to the onset of complications. 22, 23, 24 In summary, the current study reveals that SQT usage in the home for patients at risk for early delivery offers a significant advantage when compared to prolonged hospitalization for tocolytic therapy. Because of the increased gestational age at delivery and fewer low birth weight infants, there were significantly lower costs associated with the care of these women compared to those managed in the hospital. Outpatient management with SQT appears to be a cost-effective and viable alternative to prolonged hospital admission for management of women with preterm labor.
